The
term breast cancer refers to a malignant tumor that has developed from cells in
the breast. This cancer is found in both
gender, but mostly in women.Usually breast cancer either begins in the cells of
the lobules (which are the milk producing glands), or the ducts (the passages
that drain milk from the lobules to the nipple). This cancer can begin in the
fatty and fibrous connective tissues of the breast. After sometimes cells of
tumour can invade surrounding to tissues and organs. Immunotherapy based drugs
have specific target cells or receptors to inhibits breast cancer.
Several
factors increases the risk of having breast cancer,that involve gender (1 in
every 150 cases in male), age (Over 80% of all female breast cancers occur
among women age of 50 years), personal history (Previous cancer history or
benign breast lump), family history (Breast cancer risk is higher among women
whose close blood relatives have this disease), the Breast Cancer Genes (Women
who carry the BRCA1 and BRCA2 genes has 40- 85% risk ), early menarche ( below
12 years old), late menopause (above 55 years old), having no children, having
a first full term pregnancy after age of 25 year, never breast feeding, using certain
kind of birth control pill (Progesterone only), use of Hormone Replacement
Therapy (HRT), increased daily fat intake (especially saturated or hydrogenated
fats), breast radiation early in life (Women who have had radiation treatment
to the chest area as a child or young adult have a greatly risk), and tobacco
smoke.
 |
| www.gapsos.com |
Studies
show that eating a lot of red or processed meats is associated with a higher
risk of breast cancer. A healthy diet such as rich in fruits and vegetables,
low fat diet, and low salted diet is generally recommended.Being overweight is
associated with increased risk of breast cancer, especially for women after
menopause, and having more fat tissue means having higher estrogen levels,
which can increase breast cancer risk.
Immunotherapy
based immunotherapeutic cancer agents such as Bevacizumab, Anti-OX40
antibody;Margetuximab, GlembatumumabVedotin, and much more are under evaluation
of various phases of the clinical trials under safety and efficacy study to
receive Food and Drug Administration (FDA) approval for the treatment of breast
cancer. Trastuzumab and Lapatinib have received approval by the
FDA for the treatment of this cancer.
Global
Allied Pharmaceuticals (GAP) has a team of experts to provide immune oncology
and immunotherapy services for the breast cancer patients.
For
more information, kindly visit us at www.gapsos.com
No comments:
Post a Comment